Issue #28 From Wall Street’s trading floors to Africa’s mobile wallets, these companies are redefining the future of finance. 💸 As global markets shift gears, two fintech powerhouses are charting very different—but equally compelling—paths to growth. On one side, Interactive Brokers Group (NASDAQ: IBKR) is thriving in a high-rate world, turning client cash into record profits and redefining efficiency with AI-driven trading tools. On the other, DLocal Limited (NASDAQ: DLO) is capturing the...
3 days ago • 11 min read
Issue #28 Investing in Pet Parents: 2 Stocks Tapping America’s $140B Pet Obsession As the pet care industry evolves, a new divide is emerging between premium growth and survival mode. On one side, Freshpet (NASDAQ: FRPT) is redefining what pet food can be—fresh, refrigerated, and profitable. On the other, Petco (NASDAQ: WOOF) is fighting to reinvent itself from a traditional retailer into a modern health and wellness platform for pets. For investors, this isn’t just about loving pets—it’s...
4 days ago • 13 min read
Issue #28 📈 Both profitable, both expanding fast and both critical to every AI workload. As the AI boom accelerates, the spotlight has shifted to the infrastructure that powers it—memory, bandwidth, and data speed. Every AI model, from ChatGPT to enterprise data engines, depends on lightning-fast chips and controllers to process and store data efficiently. That’s where the next wave of opportunity lies. 👉 Looking for exposure to the hardware backbone of the AI revolution? 👉 Want profitable,...
5 days ago • 9 min read
Issue #28 Behind Every AI Conversation: These Two Stocks Are Winning While the market’s attention remains fixed on front-end AI companies, two behind-the-scenes innovators—Agora (NASDAQ: API) and The Glimpse Group (NASDAQ: VRAR)—are quietly building the infrastructure that makes real-time, immersive digital interaction possible. Agora delivers the invisible backbone for global voice, video, and interactive streaming. After several tough years of restructuring, the company just turned...
6 days ago • 10 min read
Issue #28 Two iconic brands are reinventing themselves—and delivering results in a tough market. While much of the consumer space struggles with inflation and shifting spending habits, two brands rooted in everyday essentials—Regis Corporation (NASDAQ: RGS) and Sally Beauty Holdings (NYSE: SBH)—are proving that disciplined execution and strong brand positioning can power real comebacks. Regis Corporation, owner of Supercuts, SmartStyle, and Cost Cutters, is transforming from an operationally...
9 days ago • 12 min read
Issue #26 From the Heart to the Liver: MedTech’s Most Underrated Growth Stories While much of the medtech sector focuses on incremental upgrades, two companies are standing out for transforming how life-threatening conditions are treated — and delivering real commercial momentum in the process. Artivion (NYSE: AORT) is rapidly becoming the go-to name in complex aortic surgery. Its aortic stent grafts and mechanical heart valves are driving double-digit revenue growth, while strong clinical...
10 days ago • 13 min read
Issue #26 ⛏️ Top 2 Mining Stocks for 2025: Gold Strength Meets Copper Growth As gold prices hover near record highs and copper demand surges on the back of global electrification, two miners are standing out for their execution, balance sheet strength, and growth potential. Barrick Mining (NYSE:B) remains the gold standard among global producers. With a portfolio of Tier One mines and a laser focus on high-margin output, Barrick just posted its strongest quarterly earnings in more than a...
11 days ago • 11 min read
Issue #26 🔐 AI Marketing + Cybersecurity = 2 Big Winners You Should Know The AI revolution isn’t just reshaping industries—it’s redefining them. Two fast-growing players at the intersection of data intelligence and digital infrastructure are leading this transformation: Zeta Global (NYSE: ZETA) and SentinelOne (NYSE: S). Zeta Global is quietly becoming the backbone of AI-powered marketing, using one of the world’s largest proprietary data clouds to help brands predict and personalize customer...
12 days ago • 11 min read
Issue #24 💊 2 Biotech Stocks Actually Making Money — And What’s Next While much of the biotech sector remains driven by speculation and early-stage R&D, two commercial-stage players—Dynavax Technologies (NASDAQ: DVAX) and Esperion Therapeutics (NASDAQ: ESPR)—are proving that execution and profitability still matter. Dynavax Technologies continues to dominate the adult hepatitis B vaccine market with its best-in-class HEPLISAV-B, while expanding its pipeline with a promising shingles vaccine...
13 days ago • 12 min read